Mouseover the data points for more information. Click and drag to zoom the chart. Click on the legends to disable/enable data.

Allele | Center | Procedure / Parameter | Zygosity | Mutants | Statistical Method |
P Value | Status | |
---|---|---|---|---|---|---|---|---|

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Creatine kinase | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.829 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Creatine kinase | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.829 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Total cholesterol | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.293 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Total cholesterol | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.293 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Alpha-amylase | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.312 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Alpha-amylase | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.312 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Alkaline phosphatase | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.130 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Alkaline phosphatase | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.130 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Alanine aminotransferase | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.885 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Alanine aminotransferase | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.885 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Aspartate aminotransferase | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.111 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Aspartate aminotransferase | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.111 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Iron | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.287 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Iron | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.287 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Free fatty acid | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.227 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Free fatty acid | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.227 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Triglyceride | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.817 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Triglyceride | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.817 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Dexa-scan analysis / Fat Mass | HET | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.506 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Dexa-scan analysis / Fat Mass | HET | 7f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.506 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Magnesium | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.0377 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Magnesium | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.0377 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Fructosamine | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.0508 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Fructosamine | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.0508 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Chloride | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.959 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Chloride | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.959 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Potassium | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.0886 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Potassium | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.0886 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Sodium | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.454 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Sodium | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.454 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Creatinine | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.333 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Creatinine | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.333 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Urea | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.000271 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Urea | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.000271 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / LDL-cholesterol | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.0841 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / LDL-cholesterol | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.0841 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / HDL-cholesterol | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.300 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / HDL-cholesterol | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.300 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Glucose | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.511 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Glucose | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.511 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Total bilirubin | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.0520 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Total bilirubin | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.0520 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Dysmorphology / Body fat distribution | HET | 7f:3m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Dysmorphology / Body fat distribution | HET | 7f:3m | Fisher Exact Test framework | 1.00 | Not tested (No variation) - OK | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Calcium | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.461 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Calcium | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.461 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Albumin | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.000344 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Albumin | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.000344 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Total protein | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.00293 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Total protein | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.00293 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Glycerol | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.135 | Success | |

Grb2^{tm1a(EUCOMM)Wtsi} |
WTSI | Clinical Chemistry / Glycerol | HET | 5f:7m | Mixed Model framework, linear mixed-effects model, equation withoutWeight | 0.135 | Success |